secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2026-08-17T10:42:37+00:00
Accession:  0001104659-26-097517
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Accendra Health scraps ATM program, sells non-core assets for $45M, targets CEO successor by mid-September
--------------------------------------------------------------------------------

- Company will not implement at-the-market equity program; no impact on results or published guidance.
- Two non-core asset sales: first closed in Q3, second expected by year-end; ~$45M combined cash in Q3/Q4.
- Undrawn on $300M revolving credit facility at end of Q2; confident in liquidity position.
- CEO Pesicka to retire by end of 2026; Board expects to name successor by mid-September 2026.
- Pesicka remains CEO until successor in place, then advisory role for orderly transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000110465926097517/0001104659-26-097517-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000110465926097517/tm2622667d5_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-097517

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer